Novartis

SANDOSTATIN LAR DEPOT

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / SANDOSTATIN LAR DEPOT – J2353

Manufacturer:

Novartis

Name:

SANDOSTATIN LAR DEPOT

HCPCS Code Descriptor:

Injection, octreotide, depot form for intramuscular injection, 1 mg

Category:

J Code

HCPCS:

J2353

NDC(s):

00078-0790-61, 00078-0797-61, 00078-0804-61, 00078-0811-81, 00078-0818-81, 00078-0825-81

Primary Type:

Growth Disorder

Generic Status:

Single-Source

Route of Administration:

Intramuscular

About:

SANDOSTATIN LAR DEPOT is a Growth Disorder drug manufactured by Novartis and administered via the Intramuscular route of administration. The J Code: J2353 is aligned to the drug SANDOSTATIN LAR DEPOT.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/04

HCPCS Effective Date:

1/1/04

HCPCS Short Description:

Octreotide injection, depot

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found